|
75
|
305
|
9hdcA |
Sars-cov-2 main protease in complex with (3s)-3-[(3r)-3-phenylpiperidine-1-carbonyl]indan-1-one |
|
80
|
305
|
9hc1A |
Sars-cov-2 main protease complexed with (1r)-n-(3-chlorophenyl)-3-oxo-n-[4-(2-oxopyrrolidin-1-yl)phenyl]indane-1-carboxamide |
|
85
|
303
|
9gijA |
Crystal structure of sars-cov-2 mpro with compound 5 |
|
77
|
305
|
9hdjA |
Sars-cov-2 main protease in complex with (3r)-3-[(3r)-4-benzyl-3-phenyl-piperidine-1-carbonyl]indan-1-one |
|
79
|
306
|
9hdnA |
Sars-cov-2 main protease in complex with (1r)-3-oxo-n-[2-oxo-2-(n-phenylanilino)ethyl]indane-1-carboxamide |
|
90
|
306
|
9hakA |
Structure of compound 119 bound to sars-cov-2 main protease |
|
74
|
305
|
9hbqA |
Sars-cov-2 main protease complexed with (1r)-n-(3-chlorophenyl)-3-oxo-indane-1-carboxamide |
|
89
|
306
|
9gilA |
Crystal structure of sars-cov-2 mpro with compound 12 |
|
89
|
302
|
9glvA |
Crystal structure of sars-cov-2 mpro with ab-343. |
|
88
|
306
|
9eoxA |
Sars-cov2 major protease in covalent complex with a soluble inhibitor. |
|
90
|
306
|
9eorA |
Sars-cov2 major protease in complex with a covalent inhibitor sll12. |
|
91
|
306
|
9eo6A |
Sars-cov2 major protease in complex with a covalent inhibitor sll11. |
|
82
|
298
|
9dw6A |
Crystal structure of sars-cov-2 main protease (mpro) c145a mutant in complex with peptide from human trna methyltransferase trmt1 |
|
84
|
306
|
9cmjA |
Room-temperature x-ray structure of sars-cov-2 main protease drug resistant mutant (l50f, e166v) |
|
86
|
306
|
9cmnA |
Room-temperature x-ray structure of sars-cov-2 main protease drug resistant mutant (e166a, l167f) |
|
86
|
301
|
9cmsA |
Room-temperature x-ray structure of sars-cov-2 main protease drug resistant mutant (e166v) in complex with ensitrelvir (esv) |
|
84
|
304
|
9cmuA |
Room-temperature x-ray structure of sars-cov-2 main protease drug resistant mutant (l50f, e166v) in complex with ensitrelvir (esv) |
|
87
|
305
|
9c8qA |
Co-structure of main protease of sars-cov-2 (covid-19) with covalent inhibitor |
|
88
|
302
|
9c80A |
Co-structure of sars-cov-2 (covid-19 with covalent inhibitor |
|
85
|
298
|
8ykmA |
Crystal structure of sars-cov-2 main protease g15s mutant in complex with x77 |
|
77
|
301
|
8ykpA |
Crystal structure of sars-cov-2 main protease m49i mutant in complex with x77 |
|
81
|
299
|
8ykqA |
Crystal structure of sars-cov-2 main protease v186f mutant in complex with x77 |
|
73
|
298
|
8ykkA |
Crystal structure of sars main protease in complex with x77 |
|
83
|
298
|
8ykoA |
Crystal structure of sars-cov-2 main protease p132h mutant in complex withx77 |
|
87
|
306
|
8ylsA |
Structure of sars-cov-2 mpro in complex with its degrader |
|
80
|
294
|
8wsiA |
Crystal structure of sars-cov-2 main protease, ph=6.0 |
|
80
|
306
|
8ws3A |
Crystal structure of sars-cov-2 main protease (mpro) with covalent inhibitor 5,8-dihydroxy-1,4-naphthoquinone |
|
80
|
295
|
8wsjA |
Crystal structure of sars-cov-2 main protease, ph=6.5 |
|
82
|
296
|
8wskA |
Crystal structure of sars-cov-2 main protease, ph=8.5 |
|
82
|
295
|
8wurA |
Crystal structure of sars-cov-2 main protease d48n mutant in complex with shikonin |
|
88
|
306
|
8w1tA |
Sars-cov-2 main protease bound to a non-covalent non-peptidic hts hit |
|
85
|
301
|
8w1uA |
Sars-cov-2 main protease bound to non-covalent lead molecule nz-804 |
|
81
|
299
|
8wsjB |
Crystal structure of sars-cov-2 main protease, ph=6.5 |
|
84
|
306
|
8u9tA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi97 |
|
83
|
306
|
8u9vA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi101 |
|
84
|
306
|
8u9wA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi105 |
|
86
|
306
|
8u9nA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi64 |
|
81
|
306
|
8u9uA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi98 |
|
84
|
306
|
8u9mA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi95 |
|
82
|
306
|
8u9hA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi64 |
|
85
|
306
|
8u9kA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi94 |
|
84
|
306
|
8u4yA |
Crystal structure of sars-cov-2 main protease (mpro) l50f mutant |
|
85
|
306
|
8r1qA |
Sars-cov-2 mpro (omicron, p132h+t169s) in complex with alpha-ketoamide 13b-k |
|
84
|
305
|
8r26A |
Sars-cov-2 mpro (omicron,p132h) in complex with alpha-ketoamide 13b-k at ph 8.5 |
|
87
|
306
|
8r24A |
Sars-cov-2 mpro (omicron, p132h+t169s) free enzyme |
|
79
|
304
|
8aj1A |
Sars-cov-2 mpro in complex with rk-107 |
|
84
|
303
|
9meiA |
Crystal structure of sars-cov-2 mpro mutant l50f e166v with pfizer intravenous inhibitor pf-00835231 |
|
84
|
301
|
8z46A |
Sars-cov-2 3cl protease (3cl pro) in complex with a novel inhibitor |
|
77
|
295
|
8z1hA |
Crystal structure of sars main protease in complex with pf-00835231 |
|
87
|
300
|
8y4hA |
Crystal structure of sars-cov-2 main protease k90r mutant in complex with bofutrelvir |
